Cited by 4,511Mesenchymal stem cell researchHematopoietic Stem Cell TransplantationImmunotherapy and Immune Responses

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Human mesenchymal stem cells modulate allogeneic immune cell responses

Open access

Aggarwal, Sudeepta, Pittenger, Mark F.·2005·Blood

DOI 10.1182/blood-2004-04-1559

Open this paper in CoChat — free account Open PDF

Abstract

Mesenchymal stem cells (MSCs) are multipotent cells found in several adult tissues. Transplanted allogeneic MSCs can be detected in recipients at extended time points, indicating a lack of immune recognition and clearance. As well, a role for bone marrow-derived MSCs in reducing the incidence and severity of graft-versus-host disease (GVHD) during allogeneic transplantation has recently been reported; however, the mechanisms remain to be investigated. We examined the immunomodulatory functions of human MSCs (hMSCs) by coculturing them with purified subpopulations of immune cells and report here that hMSCs altered the cytokine secretion profile of dendritic cells (DCs), naive and effector T cells (T helper 1 [TH1] and TH2), and natural killer (NK) cells to induce a more anti-inflammatory or tolerant phenotype. Specifically, the hMSCs caused mature DCs type 1 (DC1) to decrease tumor necrosis factor α (TNF-α) secretion and mature DC2 to increase interleukin-10 (IL-10) secretion; hMSCs caused TH1 cells to decrease interferon γ (IFN-γ) and caused the TH2 cells to increase secretion of IL-4; hMSCs caused an increase in the proportion of regulatory T cells (TRegs) present; and hMSCs decreased secretion of IFN-γ from the NK cells. Mechanistically, the hMSCs produced elevated prostaglandin E2 (PGE2) in co-cultures, and inhibitors of PGE2 production mitigated hMSC-mediated immune modulation. These data offer insight into the interactions between allogeneic MSCs and immune cells and provide mechanisms likely involved with the in vivo MSC-mediated induction of tolerance that could be therapeutic for reduction of GVHD, rejection, and modulation of inflammation. (Blood. 2005;105:1815-1822)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1182/blood-2004-04-1559

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Self-citation
Mesenchymal stem cells
Caplan, A. I. (1991) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100090504 · Cited by 6,559
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS
Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J., & Kessler, P. (2002) · Circulation · doi:10.1161/hc0102.101442 · Cited by 2,234
Self-citation
CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature reviews. Immunology · doi:10.1038/nri821 · Cited by 2,097
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains
Kopen, G. C., Prockop, D. J., & Phinney, D. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10711 · Cited by 1,643
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
Meisel, R., Zibert, A., Laryea, M. D., Göbel, U., Däubener, W., & Dilloo, D. (2004) · Blood · doi:10.1182/blood-2003-11-3909 · Cited by 1,638

Show all 73 references

Research works printed but not linked: 1

Archambault MP, McIntosh KR, Duty A, Peter SJ. Allogeneic rat mesenchymal stem cells do not elicit an immune response after implantation in immunocompetent recipients [abstract]. Blood.2000;96: 762a. Abstract 3295.

Sorted by citations

Items 201–300 of 1,012

Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome
Xu, J., Wang, D., Liu, D., Fan, Z., Zhang, H., Liu, O., Ding, G., Gao, R., Zhang, C., Ding, Y., et al. (2012) · Blood · doi:10.1182/blood-2011-11-391144 · Cited by 323
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis
Vercelli, A., Mereuta, O., Garbossa, D., Muraca, G., Mareschi, K., Rustichelli, D., Ferrero, I., Mazzini, L., Madon, E., & Fagioli, F. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.016 · Cited by 310
Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment
Whiteside, T. L. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.12.003 · Cited by 314
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Kolls, J. K., Ortiz, L. A., Panoskaltsis‐Mortari, A., & Prockop, D. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200804-037dw · Cited by 308
Treatment of Inflammatory Diseases with Mesenchymal Stem Cells
Newman, R., Yoo, D. S., LeRoux, M. A., & Danilkovitch‐Miagkova, A. (2009) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152809788462635 · Cited by 309
Therapeutic Applications of Mesenchymal Stromal Cells: Paracrine Effects and Potential Improvements
Doorn, J., Moll, G., Blanc, K. L., van Blitterswijk, C., & de Boer, J. (2011) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2011.0488 · Cited by 319
Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues
Ren, G., Chen, X., Dong, F., Li, W., Ren, X., Zhang, Y., & Shi, Y. (2011) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0019 · Cited by 307
IFATS Collection: In Vivo Therapeutic Potential of Human Adipose Tissue Mesenchymal Stem Cells After Transplantation into Mice with Liver Injury
Banaś-Ząbczyk, A., Teratani, T., Yamamoto, Y., Tokuhara, M., Takeshita, F., Osaki, M., Kawamata, M., Kato, T., Okochi, H., & Ochiya, T. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0034 · Cited by 308
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
Bonin, M. V., Stölzel, F., Goedecke, A., Richter, K., Wuschek, N., Hölig, K., Platzbecker, U., Illmer, T., Schaich, M. A., Schetelig, J., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.316 · Cited by 306
Mesenchymal stem cells in arthritic diseases
Chen, F. H., & Tuan, R. S. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2514 · Cited by 304
Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair
Psaltis, P. J., Zannettino, A. C. W., Worthley, S. G., & Gronthos, S. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0428 · Cited by 303
Mesenchymal Stromal Cells: Facilitators of Successful Transplantation?
English, K., French, A., & Wood, K. J. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.09.009 · Cited by 306
Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases
Zhao, Q., Ren, H., & Han, Z. (2015) · Journal of Cellular Immunotherapy · doi:10.1016/j.jocit.2014.12.001 · Cited by 303
The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity
Zhou, Y., Yamamoto, Y., Xiao, Z., & Ochiya, T. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071025 · Cited by 303
Comparing the Immunomodulatory Properties of Bone Marrow, Adipose Tissue, and Birth-Associated Tissue Mesenchymal Stromal Cells
Mattar, P., & Bieback, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00560 · Cited by 307
Toll-Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow-Derived Mesenchymal Stem Cells by Inducing Indoleamine-2,3-dioxygenase-1 via Interferon-β and Protein Kinase R
Opitz, C. A., Litzenburger, U. M., Lutz, C., Lanz, T. V., Tritschler, I., Köppel, A., Tolosa, E., Hoberg, M., Anderl, J., Aicher, W. K., et al. (2009) · Stem Cells · doi:10.1002/stem.7 · Cited by 306
The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches
Das, R., Jahr, H., van Osch, G. J. V. M., & Farrell, E. (2010) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2009.0296 · Cited by 297
MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis
Shigemoto-Kuroda, T., Oh, J. Y., Kim, D.-K., Jeong, H. J., Park, S. Y., Lee, H. J., Park, J. W., Kim, T. W., An, S. Y., Prockop, D. J., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.04.008 · Cited by 307
Mesenchymal Stromal Cells
Bernardo, M. E., Locatelli, F., & Fibbe, W. E. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04607.x · Cited by 295
Direct Imaging of Immune Rejection and Memory Induction by Allogeneic Mesenchymal Stromal Cells
Zangi, L., Margalit, R., Reich-Zeliger, S., Bachar-Lustig, E., Beilhack, A., Negrin, R. S., & Reisner, Y. (2009) · Stem Cells · doi:10.1002/stem.217 · Cited by 292
Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes
Urbán, V. S., Kiss, J., Kovács, J., Gócza, E., Vas, V., Monostori, É., & Uher, F. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0267 · Cited by 295
Natural history of mesenchymal stem cells, from vessel walls to culture vessels
Murray, I. R., West, C. C., Hardy, W. R., James, A. W., Park, T. S., Nguyen, A. T., Tawonsawatruk, T., Lazzari, L., Soo, C. B., & Péault, B. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1462-6 · Cited by 299
Interferon-γ-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell
Stagg, J., Pommey, S., Eliopoulos, N., & Galipeau, J. (2005) · Blood · doi:10.1182/blood-2005-07-2793 · Cited by 290
Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study
Ménard, C., Hagège, A. A., Agbulut, O., Barro, M. V., Morichetti, M. C., Brasselet, C., Bel, A., Messas, E., Bissery, A., Bruneval, P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67380-1 · Cited by 290
Immunological Aspects of Allogeneic Mesenchymal Stem Cell Therapies
Griffin, M. D., Ritter, T., & Mahon, B. P. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.156 · Cited by 290
Interactions between mesenchymal stem cells and the immune system
Li, N., & Hua, J. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2473-5 · Cited by 338
A Brief Overview of Global Trends in MSC-Based Cell Therapy
Jovic, D., Yu, Y., Wang, D., Wang, K., Li, H., Xu, F., Liu, C., Liu, J., & Luo, Y. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10369-1 · Cited by 305
Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent
Joo, H. S., Suh, J. H., Lee, H. J., Bang, E. S., & Lee, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030727 · Cited by 293
Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications
Yi, T., & Song, S. U. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0202-z · Cited by 284
Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat
Curley, G. F., Hayes, M., Ansari, B., Shaw, G., Ryan, A. E., Barry, F., O’Brien, T., O’Toole, D. P., & Laffey, J. G. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-201059 · Cited by 286
The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes
Tabera, S., Perez-Simon, J. A., Diez-Campelo, M., Sanchez-Abarca, L. I., Blanco, B., Lopez, A., Benito, A., Ocio, E., Sanchez-Guijo, F. M., Canizo, C., et al. (2008) · Haematologica · doi:10.3324/haematol.12857 · Cited by 283
Current status of potential therapeutic candidates for the COVID-19 crisis
Zhang, J., Xie, B., & Hashimoto, K. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.046 · Cited by 287
Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula
Lee, W. Y., Park, K. J., Cho, Y. B., Yoon, S. N., Song, K. H., Kim, D. S., Jung, S. H., Kim, M., Yoo, H.-W., Kim, I., et al. (2013) · Stem Cells · doi:10.1002/stem.1357 · Cited by 280
Immunomodulatory properties and therapeutic application of mesenchymal stem cells
Shi, M., Liu, Z.-W., & Wang, F.-S. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04327.x · Cited by 281
Mesenchymal Stem Cells Promote Matrix Metalloproteinase Secretion by Cardiac Fibroblasts and Reduce Cardiac Ventricular Fibrosis After Myocardial Infarction
Mias, C., Lairez, O., Trouche, E., Roncalli, J. G., Calise, D., Séguélas, M., Ordener, C., Piercecchi‐Marti, M., Augè, N., Nègre‐Salvayre, A., et al. (2009) · Stem Cells · doi:10.1002/stem.169 · Cited by 280
Culture media for the differentiation of mesenchymal stromal cells
Vater, C., Kasten, P., & Stiehler, M. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.07.037 · Cited by 279
Exploring the role of stem cells in cutaneous wound healing
Lau, K., Paus, R., Tiede, S., Day, P., & Bayat, A. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00942.x · Cited by 279
Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis
Walter, J. M., Ware, L. B., & Matthay, M. A. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70217-6 · Cited by 281
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell‐therapy approaches: Further insights in the search for a fetal calf serum substitute
Bernardo, M. E., Avanzini, M. A., Perotti, C. G., Cometa, A. M., Moretta, A., Lenta, E., Fante, C. D., Novara, F., Silvestri, A. D., Amendola, G., et al. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20911 · Cited by 277
Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton’s Jelly and bone marrow sources
Najar, M., Raicevic, G., Boufker, H. I., Fayyad‐Kazan, H., Bruyn, C. D., Meuleman, N., Bron, D., Toungouz, M., & Lagneaux, L. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2010.06.006 · Cited by 277
Mesenchymal stem cell therapy for attenuation of scar formation during wound healing
Jackson, W. M., Nesti, L. J., & Tuan, R. S. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt111 · Cited by 282
Accelerated and safe expansion of human mesenchymal stromal cells in animal serum‐free medium for transplantation and regenerative medicine
Lange, C., Cakiroglu, F., Spiess, A., Cappallo‐Obermann, H., Dierlamm, J., & Zander, A. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21081 · Cited by 284
Trophic Effects of Mesenchymal Stem Cells in Tissue Regeneration
Fu, Y., Karbaat, L., Wu, L., Leijten, J., Both, S. K., & Karperien, M. (2017) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2016.0365 · Cited by 277
Mesenchymal stem cells for cartilage repair in osteoarthritis
Gupta, P. K., Das, A. K., Chullikana, A., & Majumdar, A. S. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt116 · Cited by 274
Human Adipose-Derived Mesenchymal Stem Cells for Osteoarthritis: A Pilot Study with Long-Term Follow-Up and Repeated Injections
Song, Y., Du, H. N., Dai, C., Zhang, L., Li, S., Hunter, D. J., Lu, L., & Bao, C. (2018) · Regenerative Medicine · doi:10.2217/rme-2017-0152 · Cited by 273
Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation
English, K., Barry, F., & Mahon, B. P. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.10.002 · Cited by 272
Acellular and cellular approaches to improve diabetic wound healing
Cho, H., Blatchley, M. R., Duh, E. J., & Gerecht, S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.019 · Cited by 273
Infusion of Mesenchymal Stem Cells and Rapamycin Synergize to Attenuate Alloimmune Responses and Promote Cardiac Allograft Tolerance
Ge, W., Jiang, J., Baroja, M. L., Arp, J., Zassoko, R., Liu, W., Bartholomew, A. M., García, B., & Wang, H. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02721.x · Cited by 271
Requirement of IFN-γ–Mediated Indoleamine 2,3-Dioxygenase Expression in the Modulation of Lymphocyte Proliferation by Human Adipose–Derived Stem Cells
DelaRosa, O., Lombardo, E., Beraza, A., Mancheño‐Corvo, P., Ramirez, C., Menta, R., Rico, L., Camarillo‐Retamosa, E., García‐García, L., Abad, J. L., et al. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0630 · Cited by 271
Concise Review: Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cells: Progress Toward Safe Clinical Products
Jung, Y., Bauer, G., & Nolta, J. A. (2011) · Stem Cells · doi:10.1002/stem.727 · Cited by 276
TGF-β Family Signaling in Mesenchymal DifferentiationPreprint
Grafe, I., Alexander, S., Peterson, J. R., Snider, T. N., Lévi, B., Lee, B., & Mishina, Y. M. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022202 · Cited by 278
Concise Review: Clinical Translation of Wound Healing Therapies Based on Mesenchymal Stem Cells
Jackson, W. M., Nesti, L. J., & Tuan, R. S. (2011) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0024 · Cited by 276
Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies
Iyer, S. S., & Rojas, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.5.569 · Cited by 269
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells
Chiesa, S., Morbelli, S. D., Morando, S., Massollo, M., Marini, C., Bertoni, A., Frassoni, F., Tabera, S., Sambuceti, G., Traggiai, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103650108 · Cited by 269
Mesenchymal stem cell aging
Fehrer, C., & Lepperdinger, G. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.006 · Cited by 269
Stem Cell-Derived Extracellular Vesicles and Immune-Modulation
Burrello, J., Monticone, S., Gai, C., Gomez, Y., Kholia, S., & Camussi, G. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00083 · Cited by 271
Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells
Ribeiro, A., Laranjeira, P., Mendes, S., Velada, I., Leite, C., Andrade, P., dos Santos, F., Henriques, A., Grãos, M., Cardoso, C. M. P., et al. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt336 · Cited by 275
Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes
Fattore, A. D., Luciano, R., Pascucci, L., Goffredo, B. M., Giorda, E., Scapaticci, M., Fierabracci, A., & Muraca, M. (2015) · Cell Transplantation · doi:10.3727/096368915x687543 · Cited by 270
Expanded Adipose-Derived Stem Cells Suppress Mixed Lymphocyte Reaction by Secretion of Prostaglandin E2
Cui, L., Yin, S., Liu, W., Li, N., Zhang, W., & Cao, Y. (2007) · Tissue Engineering · doi:10.1089/ten.2006.0315 · Cited by 265
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells
Gieseke, F., Böhringer, J., Bussolari, R., Dominici, M., Handgretinger, R., & Müller, I. (2010) · Blood · doi:10.1182/blood-2010-02-270777 · Cited by 269
Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy
Tan, L., Xia, M., Gao, Y., Chen, Y., & Xu, Y. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1051528 · Cited by 259
Allogeneic Human Mesenchymal Stem Cells Restore Epithelial Protein Permeability in Cultured Human Alveolar Type II Cells by Secretion of Angiopoietin-1*
Fang, X., Neyrinck, A. P., Matthay, M. A., & Lee, J. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.119917 · Cited by 258
Human Mesenchymal Stem Cells Promote Survival of T Cells in a Quiescent State
Benvenuto, F., Ferrari, S., Gerdoni, E., Gualandi, F., Frassoni, F., Pistoia, V., Mancardi, G., & Uccelli, A. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0068 · Cited by 268
Therapeutic applications of mesenchymal stromal cells
Brooke, G. P., Cook, M. M., Blair, C., Han, R., Heazlewood, C. F., Jones, B., Kambouris, M. E., Kollar, K., McTaggart, S. J., Pelekanos, R., et al. (2007) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2007.09.012 · Cited by 258
Mesenchymal stem cells for clinical application
Sensebé, L., Krampera, M., Schrezenmeier, H., Bourin, P., & Giordano, R. (2009) · Vox Sanguinis · doi:10.1111/j.1423-0410.2009.01227.x · Cited by 264
Gimme shelter: the immune system during pregnancy
Muñoz-Suano, A., Hamilton, A. B., & Betz, A. G. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01002.x · Cited by 264
Tissue Engineering at the Blood‐Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development
Radke, D., Jia, W., Sharma, D., Fena, K., Wang, G., Goldman, J., & Zhao, F. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701461 · Cited by 267
Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit?
Lazennec, G., & Jørgensen, C. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1006 · Cited by 261
Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Attenuate Hyperoxia-Induced Lung Injury in Neonatal Rats
Chang, Y. S., Oh, W., Choi, S. J., Sung, D. K., Kim, S. Y., Choi, E. Y., Kang, S., Jin, H. J., Yang, Y. S., & Park, W. S. (2009) · Cell Transplantation · doi:10.3727/096368909x471189 · Cited by 253
Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy
Schuleri, K. H., Feigenbaum, G. S., Centola, M., Weiss, E. S., Zimmet, J. M., Turney, J., Kellner, J. N., Zviman, M. M., Hatzistergos, K. E., Detrick, B., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp265 · Cited by 256
Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells
Madec, A., Mallone, R., Afonso, G., Mrad, E. A., Mesnier, A., Eljaafari, A., & Thivolet, C. H. (2009) · Diabetologia · doi:10.1007/s00125-009-1374-z · Cited by 252
Immunomodulatory Effects of Mesenchymal Stem Cells in a Rat Organ Transplant Model
Inoue, S., Popp, F., Koehl, G. E., Piso, P., Schlitt, H. J., Geissler, E. K., & Dahlke, M. H. (2006) · Transplantation · doi:10.1097/01.tp.0000209919.90630.7b · Cited by 251
Placenta‐Derived Multipotent Cells Exhibit Immunosuppressive Properties That Are Enhanced in the Presence of Interferon‐γ
Chang, C., Yen, M., Chen, Y., Chien, C., Huang, H., Bai, C., & Yen, B. L. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0071 · Cited by 251
Human Mesenchymal Stem Cells License Adult CD34+ Hemopoietic Progenitor Cells to Differentiate into Regulatory Dendritic Cells through Activation of the Notch Pathway
Li, Y., Paczesny, S., Lauret, E., Poirault‐Chassac, S., Bordigoni, P., Mekhloufi, F., Héquet, O., Bertrand, Y., Ouyang, J., Stoltz, J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1598 · Cited by 250
Mesenchymal Stem Cells: A Friend or Foe in Immune-Mediated Diseases
Gazdic, M., Volarević, V., Arsenijević, N., & Stojković, M. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9583-3 · Cited by 250
Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase
Meisel, R., Brockers, S., Heseler, K., Degistirici, Ö., Bülle, H., Woite, C., Stuhlsatz, S., Schwippert, W., Jäger, M., Sorg, R. V., et al. (2011) · Leukemia · doi:10.1038/leu.2010.310 · Cited by 249
The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy
Hoogduijn, M. J., Popp, F., Verbeek, R., Masoodi, M., Nicolaou, A., Baan, C., & Dahlke, M.-H. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.06.019 · Cited by 248
Immunosuppressive Properties of Mesenchymal Stem Cells
Abumaree, M., Jumah, M. A., Pace, R. A., & Kalionis, B. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9312-0 · Cited by 248
Monocytes Induce STAT3 Activation in Human Mesenchymal Stem Cells to Promote Osteoblast Formation
Nicolaidou, V., Wong, M. M., Redpath, A. N., Ersek, A., Baban, D. F., Williams, L. M., Cope, A. P., & Horwood, N. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039871 · Cited by 242
Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells
Ivanova‐Todorova, E., Bochev, I., Mourdjeva, M., Dimitrov, R., Bukarev, D., Kyurkchiev, S., Tivchev, P., Altŭnkova, I., & Kyurkchiev, D. S. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.07.010 · Cited by 242
The Antiproliferative Effect of Mesenchymal Stem Cells Is a Fundamental Property Shared by All Stromal Cells
Jones, S., Horwood, N. J., Cope, A. P., & Dazzi, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2824 · Cited by 245
The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke
Cunningham, C. J., Redondo-Castro, E., & Allan, S. M. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18776802 · Cited by 242
Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10
Yang, S., Park, M.-J., Yoon, I., Kim, S., Hong, S., Shin, J.-Y., Nam, H.-Y., Kim, Y.-H., Kim, B., & Park, C. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.5.035 · Cited by 241
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade III – IV acute graft‐versus‐host disease
Ball, L. M., Bernardo, M. E., Roelofs, H., van Tol, M. J. D., Contoli, B., Zwaginga, J. J., Avanzini, M. A., Conforti, A., Bertaina, A., Giorgiani, G., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12545 · Cited by 239
Although Pig Allogeneic Mesenchymal Stem Cells Are Not Immunogenic In Vitro, Intracardiac Injection Elicits an Immune Response In Vivo
Poncelet, A. J., Vercruysse, J., Saliez, A., & Gianello, P. (2007) · Transplantation · doi:10.1097/01.tp.0000258649.23081.a3 · Cited by 239
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
Weng, J., Du, X., Geng, S., Peng, Y., Wang, Z., Lu, Z. S., Wu, S., Luo, C. W., Guo, R., Ling, W., et al. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.195 · Cited by 239
Mesenchymal Stromal Cells and Cutaneous Wound Healing: A Comprehensive Review of the Background, Role, and Therapeutic Potential
Hu, M. S.-M., Borrelli, M. R., Lorenz, H. P., Longaker, M. T., & Wan, D. C. (2018) · Stem Cells International · doi:10.1155/2018/6901983 · Cited by 246
Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species
Su, J., Chen, X., Huang, Y., Li, W., Li, J., Cao, K., Cao, G., Zhang, L., Li, F., Roberts, A. I., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.149 · Cited by 238
Organization of immunological memory by bone marrow stroma
Tokoyoda, K., Hauser, A. E., Nakayama, T., & Radbruch, A. (2010) · Nature reviews. Immunology · doi:10.1038/nri2727 · Cited by 243
Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia
Aneman, I., Pienaar, D., Suvakov, S. R., Simic, T. P., Garovic, V. D., & McClements, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01864 · Cited by 239
Culture and Characterization of Mesenchymal Stem Cells From Human Gingival Tissue
Mitrano, T. I., Grob, M., Carrión, F., Nova‐Lamperti, E., Luz, P. A., Fierro, F. S., Quintero, A., Chaparro, A. P., & Sanz, A. (2010) · Journal of Periodontology · doi:10.1902/jop.2010.090566 · Cited by 234
Mesenchymal Stem Cell Therapy for Osteoarthritis: The Critical Role of the Cell Secretome
Mancuso, P., Raman, S., Glynn, A., Barry, F., & Murphy, M. J. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00009 · Cited by 238
Synovium-Derived Mesenchymal Stem Cells: A New Cell Source for Musculoskeletal Regeneration
Fan, J., Varshney, R., Ren, L., Cai, D., & Wang, D. (2009) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2008.0586 · Cited by 233
The immunomodulatory activity of human umbilical cord blood‐derived mesenchymal stem cells in vitro
Wang, M., Yang, Y. H., Yang, D., Luo, F., Liang, W., Guo, S., & Xu, J. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02891.x · Cited by 232
An educational review of cartilage repair: precepts & practice – myths & misconceptions – progress & prospects
Hunziker, E. B., Lippuner, K., Keel, M. J. B., & Shintani, N. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.12.011 · Cited by 232
Platelet Lysate Consisting of a Natural Repair Proteome Supports Human Mesenchymal Stem Cell Proliferation and Chromosomal Stability
Crespo‐Diaz, R. J., Behfar, A., Butler, G. W., Padley, D. J., Sarr, M. G., Bartunek, J., Dietz, A. B., & Terzic, A. (2010) · Cell Transplantation · doi:10.3727/096368910x543376 · Cited by 229
Biomaterial-driven in situ cardiovascular tissue engineering—a multi-disciplinary perspective
Wissing, T. B., Bonito, V., Bouten, C. V. C., & Smits, A. I. P. M. (2017) · npj Regenerative Medicine · doi:10.1038/s41536-017-0023-2 · Cited by 240
Stem cells and neurological diseases
Hess, D. C., & Borlongan, C. V. (2007) · Cell Proliferation · doi:10.1111/j.1365-2184.2008.00486.x · Cited by 229
Hematopoietic stem cells in co-culture with mesenchymal stromal cells - modeling the niche compartments in vitro
Jing, D., Fonseca, A. V., Alakel, N., Fierro, F. A., Muller, K., Bornhäuser, M., Ehninger, G., Corbeil, D., & Ordemann, R. (2010) · Haematologica · doi:10.3324/haematol.2009.010736 · Cited by 227
Hypoxic Culture Conditions as a Solution for Mesenchymal Stem Cell Based Regenerative Therapy
Haque, N., Rahman, M. T., Kasim, N. H. A., & Alabsi, A. M. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/632972 · Cited by 239

Authors: Aggarwal, S., & Pittenger, M. F.
Affiliations: Osiris Therapeutics (United States) (US)
ORCID: Pittenger, Mark F.
Venue: Blood
Publisher: American Society of Hematology
Published: 2005-02-15
Volume: 105
Issue: 4
Pages: 1815-1822
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2004-04-1559
OpenAlex: W2095666785
Cited by: 4,511
References: 73
Citations by year: 2026: 51 · 2025: 82 · 2024: 118 · 2023: 158 · 2022: 187 · 2021: 253 · 2020: 236 · 2019: 209 · 2018: 233 · 2017: 251 · 2016: 312 · 2015: 284 · 2014: 299 · 2013: 338 · 2012: 328
FWCI: 47.59
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Blood (publishedVersion)
PubMed (publishedVersion)
Funders: Osiris Therapeutics
Defense Advanced Research Projects Agency
Advanced Research Projects Agency
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: mesenchymal stem cells, immunomodulation, graft-versus-host disease, allogeneic transplantation, dendritic cells, T helper cells, natural killer cells, regulatory T cells, prostaglandin E2, cytokine production, immune tolerance, bone marrow-derived stem cells
MeSH terms: Cell Communication, Cells, Cultured, Dendritic Cells, Humans, Immunologic Factors, Immunosuppression Therapy, Killer Cells, Natural, Leukocytes, Mononuclear, Lymphocyte Activation, Mesoderm, T-Lymphocytes, Transplantation, Homologous, Dinoprostone, Coculture Techniques, Multipotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human mesenchymal stem cells modulate allogeneic immune cell responses

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks